Panminerva medica
-
The aim of this registry was to evaluate the efficacy of Meriva® in subjects with temporary kidney dysfunction (TKD) and increased oxidative stress levels. TKD was a casual finding on urinary tests after reported side effects following drug consumption, a clinical event or dehydration. ⋯ This registry study indicates that albuminuria - marker of TKD - is safely ameliorated with the standardized supplement Meriva®. Studies are needed to evaluate the effect of Meriva® in subjects with more significant clinical conditions (i.e. diabetics) or risk factors.
-
To investigate the clinical efficiency and safeness of the combination of rosuvastatin and nimodipine in treating mild cognitive impairment of cerebral small vessel disease (CSVD) patients. ⋯ The combination of rosuvastatin and nimodipine was safe and effective in treating mild cognitive impairment of CSVD patients.
-
Letter Case Reports
T4 esophageal cancer treated with radical resection.
-
Letter Case Reports
Severe toxic keratopathy after topical natamycin and ceftazidime use.